References
Chang IW, Lin JW, Wu YT (2011) The status of MGMT protein expression is a prognostic factor for meningeal hemangiopericytoma: a clinicopathologic and immunohistochemical study of 12 cases at a single institution. J Neurooncol 105:563–572
Park MS, Patel SR, Ludwig JA, Trent JC, Conrad CA, Lazar AJ, Wang WL, Boonsirikamchai P, Choi H, Wang X, Benjamin RS, Araujo DM (2011) Activity of temozolomide and bevacizumab in the treatment of locally advanced, recurrent, and metastatic hemangiopericytoma and malignant solitary fibrous tumor. Cancer 117:4939–4947
Brokinkel B, Fischer BR, Peetz-Dienhart S, Ebel H, Sepehrnia A, Rama B, Albert FK, Stummer W, Paulus W, Hasselblatt M (2010) MGMT promoter methylation status in anaplastic meningiomas. J Neurooncol 100:489–490
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Brokinkel, B., Peetz-Dienhart, S., Keyvani, K. et al. Lack of MGMT promoter hypermethylation in hemangiopericytomas of the central nervous system. J Neurooncol 110, 303–304 (2012). https://doi.org/10.1007/s11060-012-0967-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11060-012-0967-4